ALLMedicine™ Autonomic Dysreflexia Center
Research & Reviews 50 results
Rehabilitation Nursing : the Official Journal of the Asso... Alvarado V, Stutzman SE et. al.
Feb 17th, 2023 - Autonomic dysreflexia (AD) is associated with spinal cord injury, manifesting in symptoms of high blood pressure, bradycardia, headache, diaphoresis, and anxiety. Nurses often manage these symptoms; thus, nursing knowledge of AD is crucial. The pu...
The Journal of Spinal Cord Medicine; Huang M, Zheng H et. al.
Oct 22nd, 2022 - To evaluate the efficacy of intravesical injection of botulinum toxin type A (BTX-A) for neurogenic detrusor overactivity (DO) in reducing the frequency and severity of autonomic dysreflexia (AD). A cross-sectional nonrandomized trial with before ...
Journal of Neurotrauma; Walter M, Ramirez AL et. al.
Oct 1st, 2022 - The aim of this prospective phase IIa, open-label exploratory, pre-post study was to determine the efficacy of fesoterodine (i.e., 12-week treatment period) to ameliorate autonomic dysreflexia (AD) in individuals with chronic SCI (> 1-year post-in...
Spinal Cord; Gray K, Sheehan W et. al.
Aug 13th, 2022 - Systematic review. To systematically review the evidence on the use of local analgesics, specifically lidocaine or bupivacaine, to prevent autonomic dysreflexia (AD) during iatrogenic procedures or bowel and bladder care routines in individuals wi...
Spinal Cord; Rietchel L, Ramirez AL et. al.
Aug 9th, 2022 - Secondary data analysis. To characterize autonomic dysreflexia (AD) associated heart rate (HR) changes during penile vibrostimulation (PVS) and urodynamic studies (UDS). University-based laboratory. We analyzed blood pressure (BP) and HR data, rec...